1. DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 2008. 8th ed. Philadelphia: Lippincott Williams & Wilkins.
2. Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, et al. Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys. 2006; 3. 64(4):995–1001. PMID:
16406396.
Article
3. Kim WT, Nam JH, Kyuon BH, Wang SG, Kim DW. Radiotherapy for early glottic carinoma. J Korean Soc Ther Radiol Oncol. 2002; 12. 20(4):295–302.
4. Lee HS, Moon SR, Ahn KJ, Chung EJ, Suh CO, Kim GE, et al. The heterogeneity of T2NO glottic carcinoma treated by irradiation. J Korean Soc Ther Radiol. 1990; 12. 8(2):199–206.
5. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-T2 glottic carcinomas. Cancer. 2004; 5. 100(9):1786–1792. PMID:
15112257.
Article
6. Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006; 1. 64(1):77–82. PMID:
16169681.
Article
7. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003; 2. 55(2):322–328. PMID:
12527044.
Article
8. McCoul ED, Har-El G. Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma. Arch Otolaryngol Head Neck Surg. 2009; 5. 135(5):479–486. PMID:
19451470.
Article
9. Park JH, Paeng JP, Na HS, Lim KJ, Kwon SY, Jung KY, et al. Treatment results of laser cordectomy and radiation therapy for early glottic cancer. Korean J Otolaryngol-Head Neck Surg. 002; 2. 45(2):159–163.
10. Dey P, Arnold D, Wight R, MacKenzie K, Kelly C, Wilson J. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev. 2002; (2):CD002027. PMID:
12076435.
Article
11. Agrawal N, Ha PK. Management of early-stage laryngeal cancer. Otolaryngol Clin North Am. 2008; 8. 41(4):757–769. PMID:
18570957.
Article
12. Marshak G, Brenner B, Shvero J, Shapira J, Ophir D, Hochman I, et al. Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys. 1999; 3. 43(5):1009–1013. PMID:
10192348.
Article
13. Nozaki M, Furuta M, Murakami Y, Izawa Y, Iwasaki N, Takahashi H, et al. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure. Anticancer Res. 2000; Mar-Apr. 20(2B):1121–1124. PMID:
10810406.
14. Wolfensberger M, Dort JC. Endoscopic laser surgery for early glottic carcinoma: a clinical and experimental study. Laryngoscope. 1990; 10. 100(10 Pt 1):1100–1105. PMID:
2215043.
Article
15. Fowler JF. Fractionated radiation therapy after Strandqvist. Acta Radiol Oncol. 1984; 23(4):209–216. PMID:
6093436.
Article
16. Horiot JC, Bontemps P, van den Bogaert W, Le Fur R, van den Weijngaert D, Bolla M, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol. 1997; 8. 44(2):111–121. PMID:
9288839.
Article
17. Harwood AR, Tierie A. Radiotherapy of early glottic cancer-II. Int J Radiat Oncol Biol Phys. 1979; 4. 5(4):477–482. PMID:
457492.
Article
18. Randall ME, Springer DJ, Raben M. T1-T2 carcinoma of the glottis: relative hypofractionation. Radiology. 1991; 5. 179(2):569–571. PMID:
2014313.
Article
19. van der Voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998; 9. 42(2):247–255. PMID:
9788401.
Article
20. Fein DA, Lee WR, Hanlon AL, Ridge JA, Curran WJ, Coia LR. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? Int J Radiat Oncol Biol Phys. 1996; 3. 34(4):823–831. PMID:
8598359.
Article
21. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997; 8. 39(1):115–126. PMID:
9300746.
Article
22. Sakata K, Someya M, Hori M, Nakata K, Takagi M, Hareyama M. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma: consideration of time-dose factors. Strahlenther Onkol. 2008; 7. 184(7):364–369. PMID:
19016035.
23. Yu E, Shenouda G, Beaudet MP, Black MJ. Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997; 2. 37(3):587–591. PMID:
9112457.
Article
24. Rudoltz MS, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys. 1993; 8. 26(5):767–772. PMID:
8344844.
Article
25. Kim YH, Chai GY. Radiotherapy of early stage glottic cancer. J Korean Soc Ther Radiol. 1997; 12. 15(4):315–320.
26. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001; 10. 19(20):4029–4036. PMID:
11600604.
Article
27. Nibu K, Kamata S, Kawabata K, Nakamizo M, Nigauri T, Hoki K. Partial laryngectomy in the treatment of radiation-failure of early glottic carcinoma. Head Neck. 1997; 3. 19(2):116–120. PMID:
9059868.
Article
28. Fujita M, Rudoltz MS, Canady DJ, Patel P, Machtay M, Pittard MQ, et al. Second malignant neoplasia in patients with T1 glottic cancer treated with radiation. Laryngoscope. 1998; 12. 108(12):1853–1855. PMID:
9851503.
Article
29. Narayana A, Vaughan AT, Fisher SG, Reddy SP. Second primary tumors in laryngeal cancer: results of long-term follow-up. Int J Radiat Oncol Biol Phys. 1998; 10. 42(3):557–562. PMID:
9806515.
Article
30. Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, et al. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer. 2003; 8. 98(4):765–772. PMID:
12910521.